Multiple Myeloma
Interventions of Interest: Carfilzomib (Kyprolis®, Onyx) Daratumumab (Darzalex®, Janssen Bitoech) Elotuzumab (Empliciti®, Bristol MeyersSquibb) Ixazomib (Ninlaro®, Takeda) Panobinostat (Farydak®, Novartis Pharmaceuticals Corp.) Pomalidomide (Pomalyst®, Celgene) Multiple myeloma is a cancer of the blood in which the bone marrow produces a high number of cancerous plasma cells. The excessive growth of plasma cells can cause bone […]